Skip to main content

Table 3 Comparison of HCAP risk factors between MRSA and non-MRSA pneumonia a

From: Prediction of methicillin-resistant Staphylococcus aureusin patients with non-nosocomial pneumonia

Risk factors

MRSA

Non-MRSA

P-value

Hospitalization for ≥ 2 d in the preceding 90d

50 (64.1)

313 (36.2)

< 0.001

Residence in a nursing home or extended care facility

16 (20.5)

74 (8.6)

0.001

Intravenous antibiotic treatment within 30 days

22 (28.2)

80 (9.2)

<0.001

Chemotherapy within 30 days of pneumonia

6 (7.7)

115 (13.3)

0.156

Wound care within 30 days of pneumonia

1 (1.3)

4 (0.5)

0.351

Hemodialysis clinic

2 (2.6)

30 (3.5)

1

  1. aData are presented as numbers (percentages) unless otherwise indicated.
  2. Abbreviations: HCAP healthcare-associated pneumonia, MRSA methicillin-resistant Staphylococcus aureus.